Synthesis and antimelanoma activity of sterically congested tertiary amide analogues of N-acetyl-4-S-cysteaminylphenol

Oncology Research

Volumn 15, Issue 2, 2005, Pages 87-94

  Ferguson, Jillian ^a   Rogers, Paul M ^b,c   Kelland, Lloyd R ^b,c   Robins, David J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Amide; Antimelanoma; Cysteaminylphenol; Tyrosinase

Indexed keywords

ACETAMIDE DERIVATIVE; ACETIC ACID DERIVATIVE; AMIDE; CELL ENZYME; CISPLATIN; CYCLOHEXANE DERIVATIVE; CYSTEINE DERIVATIVE; MELANIN; MONOPHENOL MONOOXYGENASE; N ACETYL 4 S CYSTEAMINYLPHENOL; N [2 [(4 HYDROXYPHENYL)THIO] 1,1 DIMETHYLETHYL] N ETHYLACETAMIDE; N [2 [(4 HYDROXYPHENYL)THIO] 1,1 DIMETHYLETHYL] N METHYLCYCLOHEXANECARBOXAMIDE; NITROGEN; PHENOL DERIVATIVE; QUINONE DERIVATIVE; THIOL DERIVATIVE; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

ALKYLATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HYDROLYSIS; IC 50; LIPOPHILICITY; MELANOCYTE; MELANOMA; MUSHROOM; OVARY CANCER; OXIDATION; PRIORITY JOURNAL; STEREOSPECIFICITY; STRUCTURE ACTIVITY RELATION;

EID: 20444498642     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504005775082048     Document Type: Article

References (23)

1. Garbe, C.; Roderick, G.; McLeod, C.; Buettner, P. G. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer 89:1269-1278; 2000.
2. Pawlik, T. M.; Sondak, V. K. Malignant melanoma: Current state of primary and adjuvant treatment. Crit. Rev. Oncol. Haematol. 45:245-264; 2003.
3. Mohammed, K.; Sagebiel, R. W.; Collins, H. E.; Glassberg, A. B.; Allen, R. E.; Leong, S. P. L.; Small, E. J. Outpatient combination chemoimmunotherapy for patients with metastatic melanoma. Cancer 86: 2160-2165; 1999.
4. Middleton, M. R.; Grob, J. J.; Aaronson, N.; Fierlbeck, G.; Tilgen, W.; Sieter, S.; Gore, M.; Aamdal, S.; Cebon, J.; Coates, A.; Dreno, B.; Henz, M.; Schadendorf, D.; Kapp, A.; Weiss, J.; Fraass, U.; Statkevich, P.; Muller, M.; Thatcher, N. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J. Clin. Oncol. 18:158-166; 2000. (Erratum, J. Clin. Oncol. 18: 2351; 2000)
5. Prota, G.; d'Ischia, M.; Mascagna, D. Melanogenesis as a targeting strategy against metastatic melanoma-a reassessment. Melanoma Res. 4:351-358; 1994.
6. Cooksey, C. J.; Garratt, P. J.; Land, E. J.; Pavel, S.; Ramsden, C. A.; Riley, P. A.; Smit, N. P. M. Evidence of the indirect formation of the catecholic intermediate substrate responsible for the autoactivation kinetics of tyrosinase. J. Biol. Chem. 272:26226-26235; 1997.
7. Jimbow, K. N-Acetyl-4-S-cysteaminylphenol as a new type of depigmenting agent for the melanodrma of patients with melasma. Arch. Dermatol. 127:1528-1534; 1991.
8. Miura, S.; Jimbow, K.; Ito, S. The in vivo antimelanoma effect of 4-S-cysteaminylphenol and its N-acetyl derivative. Int. J Cancer 46:931-934; 1990.
9. Mascagna, D.; Constantini, C.; D'ischia, M.; Prota, G. Biomimetic oxidation of the antimelanoma agent 4-S-cysteaminylphenol and related catechol thioethers-isolation and reaction behavior of novel dihydrobenzothiazinequinones. Tetrahedron 50:8757-8764; 1994.
10. Lant, N. J.; McKeown, P.; Kelland, L. R.; Rogers, P. M.; Robins, D. J. Synthesis and antimelanoma activity of analogues of N-acetyl-4-S- cysteaminylphenol. Anticancer Drug Des. 15:295-302; 2000.
11. Lant, N.; McKeown, P.; Timoney, M. C.; Kelland, L. R.; Rogers, P. M.; Robins, D. J. Synthesis and antimelanoma activity of analogues of N-acetyl-4-S-cysteaminylphenol substituted with two methyl groups α to the nitrogen. Anticancer Drug Des. 16:49-55; 2001.
12. O'Connor, C. Acidic and basic amide hydrolysis. Q. Rev. Chem. Soc. 24:553-564; 1970.
13. Padgette, S. R.; Hermann, H. H.; Han, J. H.; Pollock, S. H.; May, S. W. Antihypertensive activities of phenyl aminoethyl sulfides, a class of synthetic substrates for dopamine beta-hydroxylase. J. Med. Chem. 27:1354-1357; 1984.
14. Pearson, V. C.; Ferguson, J.; Rogers, P. M.; Kelland, L. R.; Robins, D. J. Synthesis and antimelanoma activity of tertiary amide analogues of N-acetyl-4-S-cysteaminylphenol. Oncol. Res. 13:503-512; 2003.
15. Naish-Byfield, S.; Cooksey, C. J.; Latter, A. M.; Johnson, C. I.; Riley, P. A. In vitro assessment of the structure-activity relationship of tyrosinase-dependent cytotoxicity of a series of substituted phenols. Melanoma Res. 1:273-287; 1991.
16. Mascagna, D.; Constantini, C.; D'ischia, M.; Prota, G. Biomimetic oxidation of the antimelanoma agent 4-S-cysteaminylphenol and related catechol thioethers-isolation and reaction behaviour of novel dihydrobenzothiazinequinones. Tetrahedron 50:8757-8764; 1994.
17. Leonard, J.; Lygo, B.; Procter, G. Advanced practical organic chemistry, 2nd ed. Oxford: Chapman and Hall; 1995.
18. Orito, K.; Kaga, H.; Ito, M. Benzolactams 2. Synthesis of tetrahydrobenz[d]indeno[1,2-b]azepines and their 1,2-oxo derivatives. J. Heterocyclic Chem. 17:417-423; 1980.
19. McOmie, J. F. W.; Watts, M. L.; West, D. E. Demethylation of aryl methyl ethers by boron tribromide. Tetrahedron 24:2289-2292; 1967.
20. Bogdal, D. Fast solvent-free alkylation of amides and lactams under microwave irradiation. Molecules 4:333-337; 1999.
21. Barton, D. H. R.; Motherwell, W. B.; Wozniak, J.; Zard, S. Z. An efficient and short degradation of the cholic acid side chain: A new method for the preparation and dehydrogenation of 4,5-dihydro-oxazoles. J. Chem. Soc. Perkin Trans. 1:1865-1869; 1985.
22. Duckworth, H. W.; Coleman, J. E. Physicochemical and kinetic properties of mushroom tyrosinase. J. Biol. Chem. 245:1613-1625; 1970.
23. Kelland, L. R.; Barnard, C. F. J.; Mellish, K. J.; Jones, M.; Goddard, P. M.; Valenti, M.; Bryant, A.; Murrer, B. A.; Harrap, K. R. A novel trans platinum coordination complex possessing in vitro and in vivo antitumor activity. Cancer Res. 54:5618-5622; 1994.